Company / Free Cash Flow
AYTU BIOPHARMA, INC Free Cash Flow History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$2.2M
FY2025
5-year range
-$28.8M / -$1.7M
FY2021-FY2025
Trend
-26.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow has fluctuated over the past 9 years, ranging from -$29M in FY2022 to -$2M in FY2024.
Based on SEC 10-K filings.
-$2M in FY2025.
Improved from -$29M to -$2M over the past 3 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow decreased 26.1% year-over-year.
- Peak free cash flow was recorded in FY2024.
- Lowest free cash flow in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.2M | -26.1% |
| FY2024 | -$1.7M | - |
| FY2023 | - | - |
| FY2022 | -$28.8M | -1.8% |
| FY2021 | -$28.3M | +0.2% |
| FY2020 | -$28.4M | -77.2% |
| FY2018 | -$16.0M | -14.9% |
| FY2017 | -$13.9M | -27.8% |
| FY2016 | -$10.9M | -64.5% |
| FY2015 | -$6.6M | -1793.5% |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026